US shutdown sends airlines scrambling as travel chaos looms
Flight cuts set to be ordered at 40 busiest U.S. airports due to shutdownAirlines face staffing shortages, causing…
Top FDA regulator accused of using office to settle personal vendetta
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at…
Medicare will officially reduce payments for surgeries, outpatient procedures
Tara Bannow covers hospitals, providers, and insurers. You can reach Tara on Signal at tarabannow.70. Medicare on Friday…
FDA approves Blenrep, a GSK blood cancer drug with unusual history
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at…
Medicare payments to doctors paused as shutdown drags on
Tara Bannow covers hospitals, providers, and insurers. You can reach Tara on Signal at tarabannow.70. The Centers for…
Trump’s 100% pharma tariff, promised Oct. 1, is delayed
WASHINGTON — President Trump told pharmaceutical companies last week that they should start building infrastructure in the U.S.…
Summit Therapeutics hits possible snag on lung cancer drug seen as blockbuster
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall…
RFK Jr.’s CDC reform plan is similar to secret Susan Monarez memo
WASHINGTON — In the days after health secretary Robert F. Kennedy Jr. pushed out the director of the…
Pfizer defends Covid vaccine effectiveness in response to Trump
Pfizer CEO Albert Bourla on Wednesday defended the development of Covid vaccinations, including Pfizer’s own, suggesting that they…
House bill on HHS budget: NIH funding maintained, deep CDC cuts
WASHINGTON — House appropriators advanced legislation on Tuesday that is a mixed bag for researchers. While the Republican…
Viking Therapeutics oral weight loss drug hits mark in mid-stage trial
Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and…
Vinay Prasad returns to the FDA, weeks after his ouster
WASHINGTON — Vinay Prasad is returning to the Food and Drug Administration to resume his role overseeing vaccine,…